ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Androgenic Alopecia Therapeutics Market Insights, Forecast to 2030
Published Date: December 2024
|
Report Code: QYRE-Auto-33M14612
Home | Market Reports | Health| Pharmacy
Global Androgenic Alopecia Therapeutics Market Insights Forecast to 2029
BUY CHAPTERS

Global Androgenic Alopecia Therapeutics Market Insights, Forecast to 2030

Code: QYRE-Auto-33M14612
Report
December 2024
Pages:114
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Johnson & Johnson
Merck
GlaxoSmithKline PLC
Astellas Pharma
Cipla Ltd
Almirall
Sun Pharma
Reddy's Laboratories
Concert Pharmaceuticals
RiverTown Therapeutics
Brickell Biotech
BiologicsMD
Aclaris Therapeutics

Androgenic Alopecia Therapeutics Market

Androgenic Alopecia refers to the phenomenon of hair loss, including natural hair loss and pathological hair loss caused by various reasons.
Market Analysis and Insights: Global Androgenic Alopecia Therapeutics Market
The global Androgenic Alopecia Therapeutics market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Androgenic Alopecia Therapeutics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Androgenic Alopecia Therapeutics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for Androgenic Alopecia Therapeutics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key companies of Androgenic Alopecia Therapeutics include Johnson & Johnson, Merck, GlaxoSmithKline, Astellas Pharma, Cipla, Almirall, Sun Pharma, Reddy's Laboratories and Concert Pharmaceuticals, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Androgenic Alopecia Therapeutics is widely used in various fields, such as Hospital, Clinic and Other,, etc. Hospital provides greatest supports to the Androgenic Alopecia Therapeutics industry development. In 2023, global % revenue of Androgenic Alopecia Therapeutics went into Hospital filed and the proportion will reach to % in 2030.
Report Covers:
This report presents an overview of global market for Androgenic Alopecia Therapeutics market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Androgenic Alopecia Therapeutics, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Androgenic Alopecia Therapeutics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Androgenic Alopecia Therapeutics revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Androgenic Alopecia Therapeutics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Androgenic Alopecia Therapeutics revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of Androgenic Alopecia Therapeutics Market Report

Report Metric Details
Report Name Androgenic Alopecia Therapeutics Market
Segment by Type
Segment by Application
  • Hospital
  • Clinic
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Johnson & Johnson, Merck, GlaxoSmithKline, Astellas Pharma, Cipla, Almirall, Sun Pharma, Reddy's Laboratories, Concert Pharmaceuticals, RiverTown Therapeutics, Brickell Biotech, BiologicsMD, Aclaris Therapeutics
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Revenue of Androgenic Alopecia Therapeutics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Androgenic Alopecia Therapeutics companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
  • Chapter 8: China by Type, and by Application, revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
  • Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Androgenic Alopecia Therapeutics revenue, gross margin, and recent development, etc.
  • Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

Who are the main players in the Androgenic Alopecia Therapeutics Market report?

Ans: The main players in the Androgenic Alopecia Therapeutics Market are Johnson & Johnson, Merck, GlaxoSmithKline, Astellas Pharma, Cipla, Almirall, Sun Pharma, Reddy's Laboratories, Concert Pharmaceuticals, RiverTown Therapeutics, Brickell Biotech, BiologicsMD, Aclaris Therapeutics

What are the Application segmentation covered in the Androgenic Alopecia Therapeutics Market report?

Ans: The Applications covered in the Androgenic Alopecia Therapeutics Market report are Hospital, Clinic, Other

What are the Type segmentation covered in the Androgenic Alopecia Therapeutics Market report?

Ans: The Types covered in the Androgenic Alopecia Therapeutics Market report are Medicine, Surgery, Other

Recommended Reports

Hair Loss Therapeutics

Dermatology & Cosmetic

Therapeutic Medicines

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Androgenic Alopecia Therapeutics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Medicine
1.2.3 Surgery
1.2.4 Other
1.3 Market by Application
1.3.1 Global Androgenic Alopecia Therapeutics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Androgenic Alopecia Therapeutics Market Perspective (2019-2030)
2.2 Global Androgenic Alopecia Therapeutics Growth Trends by Region
2.2.1 Androgenic Alopecia Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Androgenic Alopecia Therapeutics Historic Market Size by Region (2019-2024)
2.2.3 Androgenic Alopecia Therapeutics Forecasted Market Size by Region (2025-2030)
2.3 Androgenic Alopecia Therapeutics Market Dynamics
2.3.1 Androgenic Alopecia Therapeutics Industry Trends
2.3.2 Androgenic Alopecia Therapeutics Market Drivers
2.3.3 Androgenic Alopecia Therapeutics Market Challenges
2.3.4 Androgenic Alopecia Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Androgenic Alopecia Therapeutics by Players
3.1.1 Global Androgenic Alopecia Therapeutics Revenue by Players (2019-2024)
3.1.2 Global Androgenic Alopecia Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global Androgenic Alopecia Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Androgenic Alopecia Therapeutics, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Androgenic Alopecia Therapeutics Market Concentration Ratio
3.4.1 Global Androgenic Alopecia Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Androgenic Alopecia Therapeutics Revenue in 2023
3.5 Global Key Players of Androgenic Alopecia Therapeutics Head office and Area Served
3.6 Global Key Players of Androgenic Alopecia Therapeutics, Product and Application
3.7 Global Key Players of Androgenic Alopecia Therapeutics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Androgenic Alopecia Therapeutics Breakdown Data by Type
4.1 Global Androgenic Alopecia Therapeutics Historic Market Size by Type (2019-2024)
4.2 Global Androgenic Alopecia Therapeutics Forecasted Market Size by Type (2025-2030)
5 Androgenic Alopecia Therapeutics Breakdown Data by Application
5.1 Global Androgenic Alopecia Therapeutics Historic Market Size by Application (2019-2024)
5.2 Global Androgenic Alopecia Therapeutics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Androgenic Alopecia Therapeutics Market Size (2019-2030)
6.2 North America Androgenic Alopecia Therapeutics Market Size by Type
6.2.1 North America Androgenic Alopecia Therapeutics Market Size by Type (2019-2024)
6.2.2 North America Androgenic Alopecia Therapeutics Market Size by Type (2025-2030)
6.2.3 North America Androgenic Alopecia Therapeutics Market Share by Type (2019-2030)
6.3 North America Androgenic Alopecia Therapeutics Market Size by Application
6.3.1 North America Androgenic Alopecia Therapeutics Market Size by Application (2019-2024)
6.3.2 North America Androgenic Alopecia Therapeutics Market Size by Application (2025-2030)
6.3.3 North America Androgenic Alopecia Therapeutics Market Share by Application (2019-2030)
6.4 North America Androgenic Alopecia Therapeutics Market Size by Country
6.4.1 North America Androgenic Alopecia Therapeutics Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Androgenic Alopecia Therapeutics Market Size by Country (2019-2024)
6.4.3 North America Androgenic Alopecia Therapeutics Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Androgenic Alopecia Therapeutics Market Size (2019-2030)
7.2 Europe Androgenic Alopecia Therapeutics Market Size by Type
7.2.1 Europe Androgenic Alopecia Therapeutics Market Size by Type (2019-2024)
7.2.2 Europe Androgenic Alopecia Therapeutics Market Size by Type (2025-2030)
7.2.3 Europe Androgenic Alopecia Therapeutics Market Share by Type (2019-2030)
7.3 Europe Androgenic Alopecia Therapeutics Market Size by Application
7.3.1 Europe Androgenic Alopecia Therapeutics Market Size by Application (2019-2024)
7.3.2 Europe Androgenic Alopecia Therapeutics Market Size by Application (2025-2030)
7.3.3 Europe Androgenic Alopecia Therapeutics Market Share by Application (2019-2030)
7.4 Europe Androgenic Alopecia Therapeutics Market Size by Country
7.4.1 Europe Androgenic Alopecia Therapeutics Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Androgenic Alopecia Therapeutics Market Size by Country (2019-2024)
7.4.3 Europe Androgenic Alopecia Therapeutics Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Androgenic Alopecia Therapeutics Market Size (2019-2030)
8.2 China Androgenic Alopecia Therapeutics Market Size by Type
8.2.1 China Androgenic Alopecia Therapeutics Market Size by Type (2019-2024)
8.2.2 China Androgenic Alopecia Therapeutics Market Size by Type (2025-2030)
8.2.3 China Androgenic Alopecia Therapeutics Market Share by Type (2019-2030)
8.3 China Androgenic Alopecia Therapeutics Market Size by Application
8.3.1 China Androgenic Alopecia Therapeutics Market Size by Application (2019-2024)
8.3.2 China Androgenic Alopecia Therapeutics Market Size by Application (2025-2030)
8.3.3 China Androgenic Alopecia Therapeutics Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Androgenic Alopecia Therapeutics Market Size (2019-2030)
9.2 Asia Androgenic Alopecia Therapeutics Market Size by Type
9.2.1 Asia Androgenic Alopecia Therapeutics Market Size by Type (2019-2024)
9.2.2 Asia Androgenic Alopecia Therapeutics Market Size by Type (2025-2030)
9.2.3 Asia Androgenic Alopecia Therapeutics Market Share by Type (2019-2030)
9.3 Asia Androgenic Alopecia Therapeutics Market Size by Application
9.3.1 Asia Androgenic Alopecia Therapeutics Market Size by Application (2019-2024)
9.3.2 Asia Androgenic Alopecia Therapeutics Market Size by Application (2025-2030)
9.3.3 Asia Androgenic Alopecia Therapeutics Market Share by Application (2019-2030)
9.4 Asia Androgenic Alopecia Therapeutics Market Size by Region
9.4.1 Asia Androgenic Alopecia Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Androgenic Alopecia Therapeutics Market Size by Region (2019-2024)
9.4.3 Asia Androgenic Alopecia Therapeutics Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Androgenic Alopecia Therapeutics Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Androgenic Alopecia Therapeutics Market Size by Type
10.2.1 Middle East, Africa, and Latin America Androgenic Alopecia Therapeutics Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Androgenic Alopecia Therapeutics Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Androgenic Alopecia Therapeutics Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Androgenic Alopecia Therapeutics Market Size by Application
10.3.1 Middle East, Africa, and Latin America Androgenic Alopecia Therapeutics Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Androgenic Alopecia Therapeutics Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Androgenic Alopecia Therapeutics Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Androgenic Alopecia Therapeutics Market Size by Country
10.4.1 Middle East, Africa, and Latin America Androgenic Alopecia Therapeutics Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Androgenic Alopecia Therapeutics Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Androgenic Alopecia Therapeutics Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Company Details
11.1.2 Johnson & Johnson Business Overview
11.1.3 Johnson & Johnson Androgenic Alopecia Therapeutics Introduction
11.1.4 Johnson & Johnson Revenue in Androgenic Alopecia Therapeutics Business (2019-2024)
11.1.5 Johnson & Johnson Recent Developments
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Merck Business Overview
11.2.3 Merck Androgenic Alopecia Therapeutics Introduction
11.2.4 Merck Revenue in Androgenic Alopecia Therapeutics Business (2019-2024)
11.2.5 Merck Recent Developments
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Details
11.3.2 GlaxoSmithKline Business Overview
11.3.3 GlaxoSmithKline Androgenic Alopecia Therapeutics Introduction
11.3.4 GlaxoSmithKline Revenue in Androgenic Alopecia Therapeutics Business (2019-2024)
11.3.5 GlaxoSmithKline Recent Developments
11.4 Astellas Pharma
11.4.1 Astellas Pharma Company Details
11.4.2 Astellas Pharma Business Overview
11.4.3 Astellas Pharma Androgenic Alopecia Therapeutics Introduction
11.4.4 Astellas Pharma Revenue in Androgenic Alopecia Therapeutics Business (2019-2024)
11.4.5 Astellas Pharma Recent Developments
11.5 Cipla
11.5.1 Cipla Company Details
11.5.2 Cipla Business Overview
11.5.3 Cipla Androgenic Alopecia Therapeutics Introduction
11.5.4 Cipla Revenue in Androgenic Alopecia Therapeutics Business (2019-2024)
11.5.5 Cipla Recent Developments
11.6 Almirall
11.6.1 Almirall Company Details
11.6.2 Almirall Business Overview
11.6.3 Almirall Androgenic Alopecia Therapeutics Introduction
11.6.4 Almirall Revenue in Androgenic Alopecia Therapeutics Business (2019-2024)
11.6.5 Almirall Recent Developments
11.7 Sun Pharma
11.7.1 Sun Pharma Company Details
11.7.2 Sun Pharma Business Overview
11.7.3 Sun Pharma Androgenic Alopecia Therapeutics Introduction
11.7.4 Sun Pharma Revenue in Androgenic Alopecia Therapeutics Business (2019-2024)
11.7.5 Sun Pharma Recent Developments
11.8 Reddy's Laboratories
11.8.1 Reddy's Laboratories Company Details
11.8.2 Reddy's Laboratories Business Overview
11.8.3 Reddy's Laboratories Androgenic Alopecia Therapeutics Introduction
11.8.4 Reddy's Laboratories Revenue in Androgenic Alopecia Therapeutics Business (2019-2024)
11.8.5 Reddy's Laboratories Recent Developments
11.9 Concert Pharmaceuticals
11.9.1 Concert Pharmaceuticals Company Details
11.9.2 Concert Pharmaceuticals Business Overview
11.9.3 Concert Pharmaceuticals Androgenic Alopecia Therapeutics Introduction
11.9.4 Concert Pharmaceuticals Revenue in Androgenic Alopecia Therapeutics Business (2019-2024)
11.9.5 Concert Pharmaceuticals Recent Developments
11.10 RiverTown Therapeutics
11.10.1 RiverTown Therapeutics Company Details
11.10.2 RiverTown Therapeutics Business Overview
11.10.3 RiverTown Therapeutics Androgenic Alopecia Therapeutics Introduction
11.10.4 RiverTown Therapeutics Revenue in Androgenic Alopecia Therapeutics Business (2019-2024)
11.10.5 RiverTown Therapeutics Recent Developments
11.11 Brickell Biotech
11.11.1 Brickell Biotech Company Details
11.11.2 Brickell Biotech Business Overview
11.11.3 Brickell Biotech Androgenic Alopecia Therapeutics Introduction
11.11.4 Brickell Biotech Revenue in Androgenic Alopecia Therapeutics Business (2019-2024)
11.11.5 Brickell Biotech Recent Developments
11.12 BiologicsMD
11.12.1 BiologicsMD Company Details
11.12.2 BiologicsMD Business Overview
11.12.3 BiologicsMD Androgenic Alopecia Therapeutics Introduction
11.12.4 BiologicsMD Revenue in Androgenic Alopecia Therapeutics Business (2019-2024)
11.12.5 BiologicsMD Recent Developments
11.13 Aclaris Therapeutics
11.13.1 Aclaris Therapeutics Company Details
11.13.2 Aclaris Therapeutics Business Overview
11.13.3 Aclaris Therapeutics Androgenic Alopecia Therapeutics Introduction
11.13.4 Aclaris Therapeutics Revenue in Androgenic Alopecia Therapeutics Business (2019-2024)
11.13.5 Aclaris Therapeutics Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
FEATURED COMPANIES
Johnson & Johnson
Merck
GlaxoSmithKline PLC
Astellas Pharma
Cipla Ltd
Almirall
Sun Pharma
Reddy's Laboratories
Concert Pharmaceuticals
RiverTown Therapeutics
Brickell Biotech
BiologicsMD
Aclaris Therapeutics
List of Tables
    Table 1. Global Androgenic Alopecia Therapeutics Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Medicine
    Table 3. Key Players of Surgery
    Table 4. Key Players of Other
    Table 5. Global Androgenic Alopecia Therapeutics Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 6. Global Androgenic Alopecia Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 7. Global Androgenic Alopecia Therapeutics Market Size by Region (2019-2024) & (US$ Million)
    Table 8. Global Androgenic Alopecia Therapeutics Market Share by Region (2019-2024)
    Table 9. Global Androgenic Alopecia Therapeutics Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 10. Global Androgenic Alopecia Therapeutics Market Share by Region (2025-2030)
    Table 11. Androgenic Alopecia Therapeutics Market Trends
    Table 12. Androgenic Alopecia Therapeutics Market Drivers
    Table 13. Androgenic Alopecia Therapeutics Market Challenges
    Table 14. Androgenic Alopecia Therapeutics Market Restraints
    Table 15. Global Androgenic Alopecia Therapeutics Revenue by Players (2019-2024) & (US$ Million)
    Table 16. Global Androgenic Alopecia Therapeutics Revenue Share by Players (2019-2024)
    Table 17. Global Top Androgenic Alopecia Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Androgenic Alopecia Therapeutics as of 2023)
    Table 18. Global Androgenic Alopecia Therapeutics Industry Ranking 2022 VS 2023 VS 2024
    Table 19. Global 5 Largest Players Market Share by Androgenic Alopecia Therapeutics Revenue (CR5 and HHI) & (2019-2024)
    Table 20. Global Key Players of Androgenic Alopecia Therapeutics, Headquarters and Area Served
    Table 21. Global Key Players of Androgenic Alopecia Therapeutics, Product and Application
    Table 22. Global Key Players of Androgenic Alopecia Therapeutics, Product and Application
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Androgenic Alopecia Therapeutics Market Size by Type (2019-2024) & (US$ Million)
    Table 25. Global Androgenic Alopecia Therapeutics Revenue Market Share by Type (2019-2024)
    Table 26. Global Androgenic Alopecia Therapeutics Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 27. Global Androgenic Alopecia Therapeutics Revenue Market Share by Type (2025-2030)
    Table 28. Global Androgenic Alopecia Therapeutics Market Size by Application (2019-2024) & (US$ Million)
    Table 29. Global Androgenic Alopecia Therapeutics Revenue Share by Application (2019-2024)
    Table 30. Global Androgenic Alopecia Therapeutics Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 31. Global Androgenic Alopecia Therapeutics Revenue Share by Application (2025-2030)
    Table 32. North America Androgenic Alopecia Therapeutics Market Size by Type (2019-2024) & (US$ Million)
    Table 33. North America Androgenic Alopecia Therapeutics Market Size by Type (2025-2030) & (US$ Million)
    Table 34. North America Androgenic Alopecia Therapeutics Market Size by Application (2019-2024) & (US$ Million)
    Table 35. North America Androgenic Alopecia Therapeutics Market Size by Application (2025-2030) & (US$ Million)
    Table 36. North America Androgenic Alopecia Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 37. North America Androgenic Alopecia Therapeutics Market Size by Country (2019-2024) & (US$ Million)
    Table 38. North America Androgenic Alopecia Therapeutics Market Size by Country (2025-2030) & (US$ Million)
    Table 39. Europe Androgenic Alopecia Therapeutics Market Size by Type (2019-2024) & (US$ Million)
    Table 40. Europe Androgenic Alopecia Therapeutics Market Size by Type (2025-2030) & (US$ Million)
    Table 41. Europe Androgenic Alopecia Therapeutics Market Size by Application (2019-2024) & (US$ Million)
    Table 42. Europe Androgenic Alopecia Therapeutics Market Size by Application (2025-2030) & (US$ Million)
    Table 43. Europe Androgenic Alopecia Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 44. Europe Androgenic Alopecia Therapeutics Market Size by Country (2019-2024) & (US$ Million)
    Table 45. Europe Androgenic Alopecia Therapeutics Market Size by Country (2025-2030) & (US$ Million)
    Table 46. China Androgenic Alopecia Therapeutics Market Size by Type (2019-2024) & (US$ Million)
    Table 47. China Androgenic Alopecia Therapeutics Market Size by Type (2025-2030) & (US$ Million)
    Table 48. China Androgenic Alopecia Therapeutics Market Size by Application (2019-2024) & (US$ Million)
    Table 49. China Androgenic Alopecia Therapeutics Market Size by Application (2025-2030) & (US$ Million)
    Table 50. Asia Androgenic Alopecia Therapeutics Market Size by Type (2019-2024) & (US$ Million)
    Table 51. Asia Androgenic Alopecia Therapeutics Market Size by Type (2025-2030) & (US$ Million)
    Table 52. Asia Androgenic Alopecia Therapeutics Market Size by Application (2019-2024) & (US$ Million)
    Table 53. Asia Androgenic Alopecia Therapeutics Market Size by Application (2025-2030) & (US$ Million)
    Table 54. Asia Androgenic Alopecia Therapeutics Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 55. Asia Androgenic Alopecia Therapeutics Market Size by Region (2019-2024) & (US$ Million)
    Table 56. Asia Androgenic Alopecia Therapeutics Market Size by Region (2025-2030) & (US$ Million)
    Table 57. Middle East, Africa, and Latin America Androgenic Alopecia Therapeutics Market Size by Type (2019-2024) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America Androgenic Alopecia Therapeutics Market Size by Type (2025-2030) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Androgenic Alopecia Therapeutics Market Size by Application (2019-2024) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Androgenic Alopecia Therapeutics Market Size by Application (2025-2030) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Androgenic Alopecia Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 62. Middle East, Africa, and Latin America Androgenic Alopecia Therapeutics Market Size by Country (2019-2024) & (US$ Million)
    Table 63. Middle East, Africa, and Latin America Androgenic Alopecia Therapeutics Market Size by Country (2025-2030) & (US$ Million)
    Table 64. Johnson & Johnson Company Details
    Table 65. Johnson & Johnson Business Overview
    Table 66. Johnson & Johnson Androgenic Alopecia Therapeutics Product
    Table 67. Johnson & Johnson Revenue in Androgenic Alopecia Therapeutics Business (2019-2024) & (US$ Million)
    Table 68. Johnson & Johnson Recent Developments
    Table 69. Merck Company Details
    Table 70. Merck Business Overview
    Table 71. Merck Androgenic Alopecia Therapeutics Product
    Table 72. Merck Revenue in Androgenic Alopecia Therapeutics Business (2019-2024) & (US$ Million)
    Table 73. Merck Recent Developments
    Table 74. GlaxoSmithKline Company Details
    Table 75. GlaxoSmithKline Business Overview
    Table 76. GlaxoSmithKline Androgenic Alopecia Therapeutics Product
    Table 77. GlaxoSmithKline Revenue in Androgenic Alopecia Therapeutics Business (2019-2024) & (US$ Million)
    Table 78. GlaxoSmithKline Recent Developments
    Table 79. Astellas Pharma Company Details
    Table 80. Astellas Pharma Business Overview
    Table 81. Astellas Pharma Androgenic Alopecia Therapeutics Product
    Table 82. Astellas Pharma Revenue in Androgenic Alopecia Therapeutics Business (2019-2024) & (US$ Million)
    Table 83. Astellas Pharma Recent Developments
    Table 84. Cipla Company Details
    Table 85. Cipla Business Overview
    Table 86. Cipla Androgenic Alopecia Therapeutics Product
    Table 87. Cipla Revenue in Androgenic Alopecia Therapeutics Business (2019-2024) & (US$ Million)
    Table 88. Cipla Recent Developments
    Table 89. Almirall Company Details
    Table 90. Almirall Business Overview
    Table 91. Almirall Androgenic Alopecia Therapeutics Product
    Table 92. Almirall Revenue in Androgenic Alopecia Therapeutics Business (2019-2024) & (US$ Million)
    Table 93. Almirall Recent Developments
    Table 94. Sun Pharma Company Details
    Table 95. Sun Pharma Business Overview
    Table 96. Sun Pharma Androgenic Alopecia Therapeutics Product
    Table 97. Sun Pharma Revenue in Androgenic Alopecia Therapeutics Business (2019-2024) & (US$ Million)
    Table 98. Sun Pharma Recent Developments
    Table 99. Reddy's Laboratories Company Details
    Table 100. Reddy's Laboratories Business Overview
    Table 101. Reddy's Laboratories Androgenic Alopecia Therapeutics Product
    Table 102. Reddy's Laboratories Revenue in Androgenic Alopecia Therapeutics Business (2019-2024) & (US$ Million)
    Table 103. Reddy's Laboratories Recent Developments
    Table 104. Concert Pharmaceuticals Company Details
    Table 105. Concert Pharmaceuticals Business Overview
    Table 106. Concert Pharmaceuticals Androgenic Alopecia Therapeutics Product
    Table 107. Concert Pharmaceuticals Revenue in Androgenic Alopecia Therapeutics Business (2019-2024) & (US$ Million)
    Table 108. Concert Pharmaceuticals Recent Developments
    Table 109. RiverTown Therapeutics Company Details
    Table 110. RiverTown Therapeutics Business Overview
    Table 111. RiverTown Therapeutics Androgenic Alopecia Therapeutics Product
    Table 112. RiverTown Therapeutics Revenue in Androgenic Alopecia Therapeutics Business (2019-2024) & (US$ Million)
    Table 113. RiverTown Therapeutics Recent Developments
    Table 114. Brickell Biotech Company Details
    Table 115. Brickell Biotech Business Overview
    Table 116. Brickell Biotech Androgenic Alopecia Therapeutics Product
    Table 117. Brickell Biotech Revenue in Androgenic Alopecia Therapeutics Business (2019-2024) & (US$ Million)
    Table 118. Brickell Biotech Recent Developments
    Table 119. BiologicsMD Company Details
    Table 120. BiologicsMD Business Overview
    Table 121. BiologicsMD Androgenic Alopecia Therapeutics Product
    Table 122. BiologicsMD Revenue in Androgenic Alopecia Therapeutics Business (2019-2024) & (US$ Million)
    Table 123. BiologicsMD Recent Developments
    Table 124. Aclaris Therapeutics Company Details
    Table 125. Aclaris Therapeutics Business Overview
    Table 126. Aclaris Therapeutics Androgenic Alopecia Therapeutics Product
    Table 127. Aclaris Therapeutics Revenue in Androgenic Alopecia Therapeutics Business (2019-2024) & (US$ Million)
    Table 128. Aclaris Therapeutics Recent Developments
    Table 129. Research Programs/Design for This Report
    Table 130. Key Data Information from Secondary Sources
    Table 131. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Androgenic Alopecia Therapeutics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Androgenic Alopecia Therapeutics Market Share by Type: 2023 VS 2030
    Figure 3. Medicine Features
    Figure 4. Surgery Features
    Figure 5. Other Features
    Figure 6. Global Androgenic Alopecia Therapeutics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 7. Global Androgenic Alopecia Therapeutics Market Share by Application: 2023 VS 2030
    Figure 8. Hospital Case Studies
    Figure 9. Clinic Case Studies
    Figure 10. Other Case Studies
    Figure 11. Androgenic Alopecia Therapeutics Report Years Considered
    Figure 12. Global Androgenic Alopecia Therapeutics Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 13. Global Androgenic Alopecia Therapeutics Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 14. Global Androgenic Alopecia Therapeutics Market Share by Region: 2023 VS 2030
    Figure 15. Global Androgenic Alopecia Therapeutics Market Share by Players in 2023
    Figure 16. Global Top Androgenic Alopecia Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Androgenic Alopecia Therapeutics as of 2023)
    Figure 17. The Top 10 and 5 Players Market Share by Androgenic Alopecia Therapeutics Revenue in 2023
    Figure 18. North America Androgenic Alopecia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 19. North America Androgenic Alopecia Therapeutics Market Share by Type (2019-2030)
    Figure 20. North America Androgenic Alopecia Therapeutics Market Share by Application (2019-2030)
    Figure 21. North America Androgenic Alopecia Therapeutics Market Share by Country (2019-2030)
    Figure 22. United States Androgenic Alopecia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 23. Canada Androgenic Alopecia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. Europe Androgenic Alopecia Therapeutics Market Size YoY (2019-2030) & (US$ Million)
    Figure 25. Europe Androgenic Alopecia Therapeutics Market Share by Type (2019-2030)
    Figure 26. Europe Androgenic Alopecia Therapeutics Market Share by Application (2019-2030)
    Figure 27. Europe Androgenic Alopecia Therapeutics Market Share by Country (2019-2030)
    Figure 28. Germany Androgenic Alopecia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. France Androgenic Alopecia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. U.K. Androgenic Alopecia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Italy Androgenic Alopecia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Russia Androgenic Alopecia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Nordic Countries Androgenic Alopecia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. China Androgenic Alopecia Therapeutics Market Size YoY (2019-2030) & (US$ Million)
    Figure 35. China Androgenic Alopecia Therapeutics Market Share by Type (2019-2030)
    Figure 36. China Androgenic Alopecia Therapeutics Market Share by Application (2019-2030)
    Figure 37. Asia Androgenic Alopecia Therapeutics Market Size YoY (2019-2030) & (US$ Million)
    Figure 38. Asia Androgenic Alopecia Therapeutics Market Share by Type (2019-2030)
    Figure 39. Asia Androgenic Alopecia Therapeutics Market Share by Application (2019-2030)
    Figure 40. Asia Androgenic Alopecia Therapeutics Market Share by Region (2019-2030)
    Figure 41. Japan Androgenic Alopecia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 42. South Korea Androgenic Alopecia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. China Taiwan Androgenic Alopecia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. Southeast Asia Androgenic Alopecia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. India Androgenic Alopecia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. Australia Androgenic Alopecia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Middle East, Africa, and Latin America Androgenic Alopecia Therapeutics Market Size YoY (2019-2030) & (US$ Million)
    Figure 48. Middle East, Africa, and Latin America Androgenic Alopecia Therapeutics Market Share by Type (2019-2030)
    Figure 49. Middle East, Africa, and Latin America Androgenic Alopecia Therapeutics Market Share by Application (2019-2030)
    Figure 50. Middle East, Africa, and Latin America Androgenic Alopecia Therapeutics Market Share by Country (2019-2030)
    Figure 51. Brazil Androgenic Alopecia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 52. Mexico Androgenic Alopecia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 53. Turkey Androgenic Alopecia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. Saudi Arabia Androgenic Alopecia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. Israel Androgenic Alopecia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. GCC Countries Androgenic Alopecia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. Johnson & Johnson Revenue Growth Rate in Androgenic Alopecia Therapeutics Business (2019-2024)
    Figure 58. Merck Revenue Growth Rate in Androgenic Alopecia Therapeutics Business (2019-2024)
    Figure 59. GlaxoSmithKline Revenue Growth Rate in Androgenic Alopecia Therapeutics Business (2019-2024)
    Figure 60. Astellas Pharma Revenue Growth Rate in Androgenic Alopecia Therapeutics Business (2019-2024)
    Figure 61. Cipla Revenue Growth Rate in Androgenic Alopecia Therapeutics Business (2019-2024)
    Figure 62. Almirall Revenue Growth Rate in Androgenic Alopecia Therapeutics Business (2019-2024)
    Figure 63. Sun Pharma Revenue Growth Rate in Androgenic Alopecia Therapeutics Business (2019-2024)
    Figure 64. Reddy's Laboratories Revenue Growth Rate in Androgenic Alopecia Therapeutics Business (2019-2024)
    Figure 65. Concert Pharmaceuticals Revenue Growth Rate in Androgenic Alopecia Therapeutics Business (2019-2024)
    Figure 66. RiverTown Therapeutics Revenue Growth Rate in Androgenic Alopecia Therapeutics Business (2019-2024)
    Figure 67. Brickell Biotech Revenue Growth Rate in Androgenic Alopecia Therapeutics Business (2019-2024)
    Figure 68. BiologicsMD Revenue Growth Rate in Androgenic Alopecia Therapeutics Business (2019-2024)
    Figure 69. Aclaris Therapeutics Revenue Growth Rate in Androgenic Alopecia Therapeutics Business (2019-2024)
    Figure 70. Bottom-up and Top-down Approaches for This Report
    Figure 71. Data Triangulation
    Figure 72. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS

Androgenetic Alopecia Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Men and Women Hair Loss Market Insights Forecast to 2030
Global Stem Cell Alopecia Treatment Market Insights Forecast to 2030
Global Medication for Hair Loss Market Research Report 2024
Global Hair Loss Treatment Products Market Research Report 2025
Global Minoxidil Market Insights Forecast to 2030
Global Hair Loss Growth Treatments and Products Market Insights Forecast to 2030
Global Hair Growth Treatment Product Market Insights Forecast to 2030
Global Androgen Antagonist Market Insights Forecast to 2030
Global Androgen Deprivation Therapy ADT Market Insights Forecast to 2030
Global Alopecia Treatment Market Research Report 2024
Global Anti Hair Loss Medicine Market Research Report 2025
Androgenetic Alopecia Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Hair Loss Prevention and Growth Product for Men Market Research Report 2024
Alopecia Hair Loss Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Antiandrogen Market Insights Forecast to 2030
Global Hair Loss Products Market Research Report 2024
Chemotherapy Induced Alopecia Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Anti Hair Loss Medication Market Research Report 2024
Global Alopecia Areata Drugs Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions